{"data":{"id":3238,"citation":"Wityak J, Prime ME, Brookfield FA, Courtney SM, Erfan S, Johnsen S, Johnson PD, Li M, Marston RW, Reed L, Vaidya D, Schaertl S, Pedret-Dunn A, Beconi M, Macdonald D, Mu\u00f1oz-Sanjuan I, Dominguez C.: SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease. ACS Med Chem Lett, Volume 3 (12), 2012","title":"SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.","doi":"10.1021\/ml300241m","doi_url":"https:\/\/doi.org\/10.1021\/ml300241m","pmid":"24900424","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/24900424\/","year":2012,"journal":"ACS Med Chem Lett","volume":"3","issue":"12","page":"1024-1028","authors":[{"first_name":"Beconi M","last_name":null,"full_name":null},{"first_name":"Brookfield FA","last_name":null,"full_name":null},{"first_name":"Courtney SM","last_name":null,"full_name":null},{"first_name":"Dominguez C.","last_name":null,"full_name":null},{"first_name":"Erfan S","last_name":null,"full_name":null},{"first_name":"Johnsen S","last_name":null,"full_name":null},{"first_name":"Johnson PD","last_name":null,"full_name":null},{"first_name":"Li M","last_name":null,"full_name":null},{"first_name":"MacDonald D","last_name":null,"full_name":null},{"first_name":"Marston RW","last_name":null,"full_name":null},{"first_name":"Munoz-Sanjuan I","last_name":null,"full_name":null},{"first_name":"Pedret-Dunn A","last_name":null,"full_name":null},{"first_name":"Prime ME","last_name":null,"full_name":null},{"first_name":"Reed L","last_name":null,"full_name":null},{"first_name":"Schaertl S","last_name":null,"full_name":null},{"first_name":"Vaidya D","last_name":null,"full_name":null},{"first_name":"Wityak J","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/3238","landing_page":"https:\/\/molmedb.upol.cz\/publication\/3238","created_at":"2024-05-21T09:16:29.000000Z","updated_at":null}}